Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 10.29% and Operating profit at 5.61% over the last 5 years
2
Flat results in Mar 25
3
With ROE of 14.06%, it has a expensive valuation with a 3.41 Price to Book Value
4
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.47%
0%
-8.47%
6 Months
-2.0%
0%
-2.0%
1 Year
-16.19%
0%
-16.19%
2 Years
-28.05%
0%
-28.05%
3 Years
-55.06%
0%
-55.06%
4 Years
-69.66%
0%
-69.66%
5 Years
-74.12%
0%
-74.12%
Topchoice Medical Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.29%
EBIT Growth (5y)
5.61%
EBIT to Interest (avg)
24.15
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.66
Tax Ratio
18.02%
Dividend Payout Ratio
40.16%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
27.45%
ROE (avg)
20.94%
Valuation key factors
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
3.41
EV to EBIT
20.05
EV to EBITDA
14.66
EV to Capital Employed
3.50
EV to Sales
4.83
PEG Ratio
NA
Dividend Yield
1.02%
ROCE (Latest)
17.43%
ROE (Latest)
14.06%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot : Jun 2017
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
700.80
699.00
0.26%
Operating Profit (PBDIT) excl Other Income
239.50
248.80
-3.74%
Interest
10.70
12.00
-10.83%
Exceptional Items
0.00
0.00
Consolidate Net Profit
164.20
163.70
0.31%
Operating Profit Margin (Excl OI)
246.90%
253.20%
-0.63%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 0.26% vs 2.22% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 0.31% vs 1.61% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
2,868.10
2,839.70
1.00%
Operating Profit (PBDIT) excl Other Income
960.10
936.80
2.49%
Interest
52.50
61.20
-14.22%
Exceptional Items
1.40
0.00
Consolidate Net Profit
572.10
578.40
-1.09%
Operating Profit Margin (Excl OI)
241.40%
243.70%
-0.23%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 1.00% vs 4.71% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -1.09% vs -6.06% in Dec 2023
About Topchoice Medical Corp. 
Topchoice Medical Corp.
Hospital
No Details Available.
Company Coordinates 
No Company Details Available






